作者:Dharmarajan Sriram、Perumal Yogeeswari、Rathinasabapathy Thirumurugan
DOI:10.1016/j.bmcl.2004.05.060
日期:2004.8
screening of new drugs for tuberculosis, we have identified N1-(4-acetamido phenyl)-N4-(2-nitro benzylidene) semicarbazone (1b), which inhibited in vitro Mycobacterium tuberculosis H(37)Rv; 100% inhibition at 1.56 microg/mL. This paper is first of its kind in which aryl semicarbazones are reported to possess antimycobacterials potency greater than p-aminosalicylic acid, ethionamide, ethambutol, ciprofloxacin
在我们的结核病新药的合成和筛选过程中,我们发现了N1-(4-乙酰氨基苯基)-N4-(2-硝基苄叉基)半卡巴zone(1b),它可以抑制体外结核分枝杆菌H( 37)Rv; 在1.56 microg / mL处有100%的抑制作用。本文是其中第一类,其中据报道芳基半咔唑酮具有比对氨基水杨酸,乙硫酰胺,乙胺丁醇,环丙沙星和卡那霉素更大的抗分枝杆菌效力。